Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950103-23-001412)

Filing Details

Accession Number:: 0000950103-23-001412
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-30 19:19:37
Reporting Period:: 2023-01-27

Accepted Time:: 2023-01-30 19:19:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356090	Precigen Inc.	PGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1886301	Jr. Harry Thomasian	C/O Precigen, Inc. 20374 Seneca Meadows Parkway Germantown, MD 20876	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-27	28,571	$1.75	84,961	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price.